CTKB
Cytek Biosciences, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$4.70
+0.00%Aug 21, 2026, 20:35 UTC
A jury in the U.S. District Court for the District of Delaware ruled in favor of Cytek Biosciences on three of four patent claims asserted by Beckman Coulter, finding noninfringement and invalidity, but found infringement under the doctrine of equivalents on one claim and awarded $56 million in damages.
Source:Aug 5, 2026, 23:11 UTC
Cytek Biosciences, Inc. reported a quarterly loss of $0.05 per share for Q2 2026, missing the Zacks Consensus Estimate of a loss of $0.02, and compared to earnings of $0.01 per share a year ago.
Jul 15, 2026, 21:00 UTC
Cytek Biosciences opened a new innovation center in Bellevue, Washington, relocating its previous Seattle-area operations to a dedicated facility for R&D and customer engagement.
Source:Jun 25, 2026, 00:00 UTC
Valerie Barnett departed as Chief Legal Officer and Corporate Secretary of Cytek Biosciences, Inc. effective June 29, 2026.
Jun 2, 2026, 00:00 UTC
Philippe Busque, Ph.D. resigned as Senior Vice President, Global Sales and Services of Cytek Biosciences, Inc., effective June 5, 2026.